Similarly, in a cohort of 187 T2DM patients monitored over a 6-year period, baseline CD34+ and CD34+CD133+ cells were lower among those with incident cardiovascular events compared to those without [56]. The gene discussed is PROM1; the disease is type 2 diabetes mellitus.